Tris Pharma
Steven Levandowski is a highly accomplished sales leader with extensive experience in the pharmaceutical industry, currently serving as Senior Regional Sales Director at Tris Pharma since May 2022, where notable achievements include leading the Presidents Club in the first half of 2025 and finishing as #1 in the nation for the Presidents Club in both 2023 and 2024. Prior experience includes serving as Regional Sales Director for Biogen in the US Alzheimer’s division, where leadership facilitated the launch of a groundbreaking Alzheimer’s treatment. Levandowski's career began at Eli Lilly and Company, followed by a long tenure at AstraZeneca, where roles spanned various therapeutic areas including cardiovascular, metabolic, and oncology, resulting in multiple awards and recognitions for leadership excellence. Levandowski holds a Bachelor of Science degree in Business with a focus on Organizational Leadership from Saint John's University.
This person is not in any teams
This person is not in any offices
Tris Pharma
1 followers
Tris Pharma, Inc. is one of the top five privately-owned specialty pharmaceutical companies in the U.S. with a focus on the development of pharmaceutical science and technology-based products. Specifically, we are engaged in research, development, manufacturing, and commercialization of both branded products and specialty generic products. We have more than a dozen solid and liquid products in the U.S. market based on our numerous NDAs and ANDAs and a rich and growing portfolio of more than 30 U.S. granted patents. Our commercialization success is driven by internal resources for our pediatric products and by licensing of our non-pediatric products to other companies.